At a glance
- Originator Procter & Gamble
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 29 Jan 1997 No-Development-Reported for Seizures in USA (Unknown route)